Chemomab Therapeutics Ltd.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2016 | — | $3.3M | $4.6M |
| FY2017 | — | $-609.0K | $1.5M |
| FY2018 | — | $9.8M | $7.5M |
| FY2019 | — | $12.4M | $17.6M |
| FY2020 | — | $10.8M | $11.7M |
| FY2021 | — | $61.5M | $15.2M |
| FY2022 | — | $36.2M | $13.5M |
| FY2023 | — | $17.0M | $9.3M |
| FY2024 | — | $13.5M | $6.1M |
| FY2025 | — | $12.3M | $7.6M |